NCT04520672Recruiting
Circulating Tumor Cells (CTC) in Cancer
Summary
This observational study with circulating tumor cells (CTC) count, isolation and analysis at several time points during disease progression is to investigate the role and biology of CTCs and clusters of CTCs in different cancer types. It also evaluates the role of CTCs as biomarkers, and aims at the identification of key signaling networks that are active in CTCs.
Inclusion criteria
• Adult cancer patients • All patients with histology-based proved diagnosis of cancer, all stages and subtypes can be included. Precancerous lesions cannot be included. • All patients with the diagnosis of a solid tumor including adenocarcinoma, squamous cell carcinoma, neuroendocrine carcinoma, sarcoma • Written pathology report must be available. • Written informed consent.
Exclusion criteria
• No written informed consent. • No proved diagnosis of malignancy by pathology report. • Patients with the diagnosis of blood cancer
Contacts
The trial team's contact details are shown on request.
See the official trial record- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Countries
- Switzerland
- Sponsor
- University Hospital, Basel, Switzerland(Other)
- Protocol no.
- 2020-00014; me19Vetter
- Conditions
- Cancer
- Interventions
- Other
Treatments studied
- Blood samples
- Samples from tumor draining vessels
Locations · 2
- Basel, SwitzerlandUniversity Hospital BaselRecruiting at this site
- Liestal, SwitzerlandDepartment Oncology, Haematology & Immuntherapy, Kantonsspital BasellandRecruiting at this site
In total, worldwide, both sites listed in the registry are recruiting.
Site status per the ClinicalTrials.gov registry (last update posted: March 12, 2025).
This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.
See also
Other versions
These results are indicative and do not replace medical advice — discuss them with your doctor.